Technical Analysis for NAVB - Navidea Biopharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 0.00 0.00% 0.00
NAVB closed unchanged on Wednesday, October 16, 2024, on 2 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 12
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Very Strong Down Down Flat

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 0.00%
Boomer Buy Setup Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Upper Bollinger Band Touch Strength 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Buy Signal Bullish 0.00%
Boomer Buy Setup Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Navidea Biopharmaceuticals, Inc. Description

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents. The company's radiopharmaceutical development programs include Lymphoseek Injection, a receptor-targeted small-molecule investigational radiopharmaceutical that is used in lymphatic mapping procedures, which are performed to help stage breast cancer and melanoma; and NAV4694, an F-18 radiolabeled positron emission tomography imaging agent, which is used as an aid in the diagnosis of patients with signs or symptoms of cognitive impairment, such as Alzheimer's disease. Its radiopharmaceutical development programs also comprise NAV5001, an Iodine-123 radiolabeled single photon emission computed tomography imaging agent that is used as an aid in the diagnosis of Parkinson's disease and other movement disorders with potential use as a diagnostic aid in dementia; and RIGScan, a radiolabeled monoclonal antibody that is developed as a diagnostic aid for use during surgery to help surgeons locate occult or metastatic cancer, primarily colorectal cancer. It has research and development agreements with University of California, AstraZeneca AB, Alseres Pharmaceuticals, Inc., and The Ohio State University. The company was formerly known as Neoprobe Corporation and changed its name to Navidea Biopharmaceuticals, Inc. in January 2012. Navidea Biopharmaceuticals, Inc. was founded in 1983 and is headquartered in Dublin, Ohio.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Surgery Monoclonal Antibody Alzheimer's Disease Breast Cancer Parkinson's Disease Melanoma Colorectal Cancer Dementia Medical Physics Movement Disorders Tomography Imaging Agent Nuclear Medicine Radiopharmaceuticals Cognitive Impairment Metastasis Iodine Positron Emission Tomography Medicinal Radiochemistry Metastatic Cancer

Is NAVB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.145
52 Week Low 0.0001
Average Volume 20,676
200-Day Moving Average 0.04
50-Day Moving Average 0.01
20-Day Moving Average 0.00
10-Day Moving Average 0.00
Average True Range 0.01
RSI (14) 50.00
ADX 53.75
+DI 88.28
-DI 6.63
Chandelier Exit (Long, 3 ATRs) 0.11
Chandelier Exit (Short, 3 ATRs) 0.02
Upper Bollinger Bands 0.00
Lower Bollinger Band 0.00
Percent B (%b) 0.0
BandWidth 0.00
MACD Line 0.00
MACD Signal Line 0.00
MACD Histogram 0.0009
Fundamentals Value
Market Cap 100.08 Thousand
Num Shares 100 Million
EPS -0.20
Price-to-Earnings (P/E) Ratio -0.01
Price-to-Sales 6110.08
Price-to-Book 8.16
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.00
Resistance 3 (R3) 0.00 0.00 0.00
Resistance 2 (R2) 0.00 0.00 0.00 0.00
Resistance 1 (R1) 0.00 0.00 0.00 0.00 0.00
Pivot Point 0.00 0.00 0.00 0.00 0.00
Support 1 (S1) 0.00 0.00 0.00 0.00 0.00
Support 2 (S2) 0.00 0.00 0.00 0.00
Support 3 (S3) 0.00 0.00 0.00
Support 4 (S4) 0.00